chr5-150521493-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2
The NM_001543.5(NDST1):c.239G>A(p.Arg80His) variant causes a missense change. The variant allele was found at a frequency of 0.00211 in 1,613,898 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 4 hom. )
Consequence
NDST1
NM_001543.5 missense
NM_001543.5 missense
Scores
2
8
9
Clinical Significance
Conservation
PhyloP100: 6.83
Genes affected
NDST1 (HGNC:7680): (N-deacetylase and N-sulfotransferase 1) This gene encodes a member of the heparan sulfate/heparin GlcNAc N-deacetylase/ N-sulfotransferase family. The encoded enzyme is a type II transmembrane protein that resides in the Golgi apparatus. The encoded protein catalyzes the transfer of sulfate from 3'-phosphoadenosine 5'-phosphosulfate to nitrogen of glucosamine in heparan sulfate. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), NDST1. . Gene score misZ 2.9238 (greater than the threshold 3.09). Trascript score misZ 4.3135 (greater than threshold 3.09). GenCC has associacion of gene with autosomal recessive non-syndromic intellectual disability, intellectual disability, autosomal recessive 46.
BP4
Computational evidence support a benign effect (MetaRNN=0.029941529).
BP6
Variant 5-150521493-G-A is Benign according to our data. Variant chr5-150521493-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 435943.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=4}.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NDST1 | NM_001543.5 | c.239G>A | p.Arg80His | missense_variant | 2/15 | ENST00000261797.7 | |
NDST1 | NM_001301063.2 | c.239G>A | p.Arg80His | missense_variant | 2/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NDST1 | ENST00000261797.7 | c.239G>A | p.Arg80His | missense_variant | 2/15 | 1 | NM_001543.5 | P1 | |
NDST1 | ENST00000523767.5 | c.239G>A | p.Arg80His | missense_variant | 2/14 | 2 | |||
NDST1 | ENST00000519157.1 | c.239G>A | p.Arg80His | missense_variant | 2/2 | 5 | |||
NDST1 | ENST00000522491.1 | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00137 AC: 209AN: 152122Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
209
AN:
152122
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00108 AC: 271AN: 251066Hom.: 1 AF XY: 0.00106 AC XY: 144AN XY: 135754
GnomAD3 exomes
AF:
AC:
271
AN:
251066
Hom.:
AF XY:
AC XY:
144
AN XY:
135754
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00219 AC: 3196AN: 1461658Hom.: 4 Cov.: 31 AF XY: 0.00211 AC XY: 1531AN XY: 727138
GnomAD4 exome
AF:
AC:
3196
AN:
1461658
Hom.:
Cov.:
31
AF XY:
AC XY:
1531
AN XY:
727138
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00137 AC: 209AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.00124 AC XY: 92AN XY: 74432
GnomAD4 genome
AF:
AC:
209
AN:
152240
Hom.:
Cov.:
32
AF XY:
AC XY:
92
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
9
ALSPAC
AF:
AC:
12
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
31
ExAC
AF:
AC:
115
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | NDST1: BS2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 14, 2019 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 28211985, 30508070, 29178990, 25125150, 21937992, 14605369, 11457867) - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 29, 2023 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 03, 2017 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 06, 2015 | - - |
Intellectual disability, autosomal recessive 46 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing;provider interpretation | Geisinger Autism and Developmental Medicine Institute, Geisinger Health System | Oct 11, 2017 | This 5-year old male with a history of global developmental delay, hyperkinesis, and mixed receptive-expressive language disorder was found to be compound heterozygous for two variants in the NDST1 gene. This variant is present in population databases at a frequency of 0.09% overall in ExAC and 0.11% in gnomAD. One homozygous individual was reported in gnomAD in an individual of non-Finnish European descent. Computational models predict this variant to be probably damaging to protein structure and/or function. This variant is located in the heparan sulfate N-deacetylase 1 domain of the protein. - |
NDST1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 08, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Intellectual disability Benign:1
Likely benign, no assertion criteria provided | clinical testing | Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille | Jan 01, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
.;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;.;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Uncertain
D;T;T
Polyphen
0.21
.;B;B
Vest4
0.40, 0.36
MVP
MPC
1.9
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at